Table 5.
Paris Region MAFACE and MALO reference centres (MAFACE, specializing in orofacial diseases and MALO, specializing in ENT) data: attractiveness by disease
| Disease | Patients % (n) | Out-of Paris Patients % (n) |
|---|---|---|
| Wiedemann-Beckwith syndrome | 1.0 (90) | 33.3 (30) |
| Goldenhar syndrome | 1.3 (117) | 55.5 (65) |
| Moebius | 1.0 (83) | 56.6 (47) |
| Treacher-Collins syndrome | 0.6 (56) | 73.2 (41) |
| Hypoglossia-hypodactyly syndrome | 0.1 (8) | 37.5 (3) |
| Binder syndrome | 0.3 (27) | 18.5 (5) |
| macroglossia (except Wiedemann-Beckwith sydrom) | 0.5 (44) | 29.5 (13) |
| Arhinie and proboscis lateralis | 0.1 (5) | 40.0 (2) |
| Cleft lip with or without cleft palate/Cleft lip and alveolus/cleft palate | 36.1 (3094) | 32.1 (994) |
| BOR syndrome | 0.6 (11) | 45.4 (5) |
| CHARGE syndrome | 0.6 (12) | 41.7 (5) |
| Weissenbacher-Zweymuller syndrome | 1.5 (27) | 29.6 (8) |
| Cysts and fistulae of the face and oral cavity/Familial thyroglossal duct cyst/Congenital laryngeal cyst/Nasolacrimal duct cyst | 0.5 (9) | 22.2 (2) |
| External auditory canal aplasia/hypoplasia/anotia/microtia | 23.4 (425) | 42.2 (182) |